Publication | Open Access

Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant

Posttransplant Lymphoproliferative DiseaseTransplantationSolid Organ TransplantMedicineImmunologyPathologyVirologyAutoimmunityGraft SurvivalAdult T-cell Leukemia-lymphomaImmunotherapyTransplant ImmunologyCell TransplantationGraft Rejection